Table 3.
Standardized mortality ratios in population-based cohort of 5-year survivors of ductal carcinoma in situ of the breast*
Cause | ICD-10 | Observed | SMR (95% CI) | AER |
---|---|---|---|---|
All causes† | A00-Y89 | 941 | 1.04 (0.97 to 1.11) | 5.7 |
Unknown cause | 6 | |||
Circulatory system | I00-99 | 195 | 0.77 (0.67 to 0.89) | −10.2 |
Myocardial infarction | I21-22 | 43 | 0.83 (0.60 to 1.11) | −1.6 |
Other ischemic heart disease | I20, 23-25 | 15 | 0.78 (0.44 to 1.29) | −0.7 |
Other heart disease | I30-33, 39-52 | 47 | 0.69 (0.50 to 0.91) | −3.8 |
Cerebrovascular disease | I60-69 | 52 | 0.77 (0.58 to 1.01) | −2.7 |
Other cardiovascular disease | I00-15, 26-28, 34-52, 70-99 | 38 | 0.83 (0.59 to 1.14) | −1.4 |
* Time at risk started 5 years after ductal carcinoma in situ diagnosis. Patients were censored at diagnosis of a second neoplasia treated with chemotherapy or radiotherapy above the diaphragm or date of emigration. AER = absolute excess risk per 10,000 patients per year; CI = confidence interval; ICD-10 = International Classification of Diseases, 10th Revision; SMR = standardized mortality ratio.
† Without taking censoring for second neoplasia into account.